{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:25:12Z","timestamp":1751534712940},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Food and Drug Safety (MFDS) of Korea","award":["14182MFDS979"],"award-info":[{"award-number":["14182MFDS979"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bbr.2017.12.026","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T18:02:16Z","timestamp":1514397736000},"page":"122-128","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels"],"prefix":"10.1016","volume":"341","author":[{"given":"Chrislean Jun","family":"Botanas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Shoon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June Bryan","family":"de la Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene Joy","family":"dela Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raly James","family":"Custodio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeseon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joung-Wook","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon-Gon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Seul","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Mi","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Sup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hoon","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2017.12.026_bib0005","author":"European Monitoring","year":"2014","journal-title":"Centre for Drugs and Drug Addiction (EMCDDA) (2014) Report on the Risk Assessment of 5-(2-aminopropyl)indole in the Framework of the Council Decision on New Psychoactive Substances"},{"key":"10.1016\/j.bbr.2017.12.026_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","article-title":"Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the poisons information centre","volume":"147","author":"Hondebrink","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"1\u20133","key":"10.1016\/j.bbr.2017.12.026_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"Eur J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.12.026_bib0020","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2015","journal-title":"New Psychoactive Substances in Europe. An Update from the EU Early Warning System"},{"key":"10.1016\/j.bbr.2017.12.026_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuropharm.2015.09.004","article-title":"The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue","volume":"101","author":"Marusich","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2017.12.026_bib0030","article-title":"Pharmacological profile of mephedrone analogs and related new psychoactive substances","author":"Luethi","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2017.12.026_bib0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/appi.ajp.2012.12091168","article-title":"A new stimulant of abuse: 5-(2-aminopropyl)indole","volume":"170","author":"Coppola","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"7\u20138","key":"10.1016\/j.bbr.2017.12.026_bib0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/dta.1530","article-title":"5-(2-aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO)","volume":"6","author":"Herraiz","year":"2014","journal-title":"Drug Test Anal."},{"issue":"11","key":"10.1016\/j.bbr.2017.12.026_bib0045","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1111\/j.1460-9568.2007.05932.x","article-title":"MDMA self\u2010administration in rats: acquisition, progressive ratio responding and serotonin transporter binding","volume":"26","author":"Schenk","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2017.12.026_bib0050","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/adb.12038","article-title":"Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and wistar rats","volume":"18","author":"Aarde","year":"2013","journal-title":"Addict. Biol."},{"issue":"5","key":"10.1016\/j.bbr.2017.12.026_bib0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bcpt.12253","article-title":"Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice","volume":"115","author":"Karlsson","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbr.2017.12.026_bib0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pbb.2016.12.017","article-title":"The abuse potential of two novel synthetic cathinones with modification on the alpha-carbon position, 2-cyclohexyl-2-(methylamino)-1-phenylethanone (MACHP) and 2-(methylamino)-1-phenyloctan-1-one (MAOP), and their effects on dopaminergic activity","volume":"153","author":"Botanas","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.bbr.2017.12.026_bib0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4062\/biomolther.2016.241","article-title":"The abuse potential of alpha-piperidinopropiophenone (PIPP) and alpha-piperidinopentiothiophenone (PIVT), two new synthetic cathinones with piperidine ring substituent","volume":"25","author":"Botanas","year":"2017","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.bbr.2017.12.026_bib0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbr.2016.10.016","article-title":"A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice","volume":"317","author":"Botanas","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.bbr.2017.12.026_bib0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2144\/000112776","article-title":"Twenty-five years of quantitative PCR for gene expression analysis","volume":"44","author":"VanGuilder","year":"2008","journal-title":"Biotechniques"},{"key":"10.1016\/j.bbr.2017.12.026_bib0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","article-title":"The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats","volume":"71","author":"Aarde","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2017.12.026_bib0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuropharm.2015.01.003","article-title":"Intravenous self-administration of mephedrone, methylone and MDMA in female rats","volume":"92","author":"Creehan","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2017.12.026_bib0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbr.2008.10.019","article-title":"Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats","volume":"198","author":"Zakharova","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2017.12.026_bib0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fnins.2016.00153","article-title":"Neuropharmacology of new psychoactive substances (NPS): focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants","volume":"10","author":"Miliano","year":"2016","journal-title":"Front. Neurosci."},{"issue":"8","key":"10.1016\/j.bbr.2017.12.026_bib0100","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/sj.npp.1301309","article-title":"Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice","volume":"32","author":"Daza-Losada","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2017.12.026_bib0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2016.08.002","article-title":"5-(2-aminopropyl)benzofuran and phenazepam demonstrate the possibility of dependence by increasing dopamine levels in the brain","volume":"149","author":"Cha","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2017.12.026_bib0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2016.08.002","article-title":"5-(2-aminopropyl) benzofuran and phenazepam demonstrate the possibility of dependence by increasing dopamine levels in the brain","volume":"149","author":"Cha","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.bbr.2017.12.026_bib0115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbr.2009.10.038","article-title":"Behavioral, thermal and neurochemical effects of acute and chronic 3, 4-methylenedioxymethamphetamine (\u201cEcstasy\u201d) self-administration","volume":"207","author":"Reveron","year":"2010","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2017.12.026_bib0120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.physbeh.2006.06.021","article-title":"Experience-dependent changes in temperature and behavioral activity induced by MDMA","volume":"89","author":"Reveron","year":"2006","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2017.12.026_bib0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","article-title":"The role of serotonin in drug use and addiction","volume":"277","author":"M\u00fcller","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2017.12.026_bib0130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF02244137","article-title":"Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin","volume":"101","author":"Loh","year":"1990","journal-title":"Psychopharmacology (Berl.)"},{"issue":"5","key":"10.1016\/j.bbr.2017.12.026_bib0135","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/adb.12069","article-title":"Acquisition of MDMA self\u2010administration: pharmacokinetic factors and MDMA\u2010induced serotonin release","volume":"19","author":"Bradbury","year":"2014","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.bbr.2017.12.026_bib0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1124\/jpet.301.2.698","article-title":"Relative reinforcing effects of three opioids with different durations of action","volume":"301","author":"Ko","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbr.2017.12.026_bib0145","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.301.2.690","article-title":"Relative reinforcing strength of three N-methyl-d-aspartate antagonists with different onsets of action","volume":"301","author":"Winger","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbr.2017.12.026_bib0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0091-3057(00)00185-4","article-title":"Simultaneous monitoring of conditioned place preference and locomotor sensitization following repeated administration of cocaine and methamphetamine","volume":"66","author":"Shimosato","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.bbr.2017.12.026_bib0155","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.euroneuro.2012.09.005","article-title":"Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat","volume":"23","author":"Shortall","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2017.12.026_bib0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s002130000463","article-title":"Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area","volume":"151","author":"Vezina","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.bbr.2017.12.026_bib0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","article-title":"A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants","volume":"25","author":"Pierce","year":"1997","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.bbr.2017.12.026_bib0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/npp.2009.143","article-title":"Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol","volume":"35","author":"Valjent","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2017.12.026_bib0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-4328(02)00286-3","article-title":"Nucleus accumbens shell and core dopamine: differential role in behavior and addiction","volume":"137","author":"Di Chiara","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2017.12.026_bib0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.coph.2006.11.003","article-title":"Reward system and addiction: what dopamine does and doesn't do","volume":"7","author":"Di Chiara","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2017.12.026_bib0185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coph.2004.08.011","article-title":"Synaptic plasticity and drug addiction","volume":"5","author":"Jones","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2017.12.026_bib0190","doi-asserted-by":"crossref","first-page":"431","DOI":"10.31887\/DCNS.2013.15.4\/enestler","article-title":"Cellular basis of memory for addiction","volume":"15","author":"Nestler","year":"2013","journal-title":"Dialogues Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2017.12.026_bib0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02244342","article-title":"Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats","volume":"113","author":"Ranaldi","year":"1993","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.bbr.2017.12.026_bib0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/adb.12299","article-title":"The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity","volume":"22","author":"Hwang","year":"2017","journal-title":"Addict. Biol."},{"issue":"4","key":"10.1016\/j.bbr.2017.12.026_bib0205","first-page":"446","article-title":"Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide","volume":"33","author":"Landa","year":"2012","journal-title":"Neuro Endocrinol. Lett."},{"issue":"1","key":"10.1016\/j.bbr.2017.12.026_bib0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2004.03.053","article-title":"Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain","volume":"363","author":"Li","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.bbr.2017.12.026_bib0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/10673220490910844","article-title":"Neurobiologic processes in drug reward and addiction","volume":"12","author":"Adinoff","year":"2004","journal-title":"Harv. Rev. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2017.12.026_bib0220","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","article-title":"Dopamine and drug addiction: the nucleus accumbens shell connection","volume":"47","author":"Di Chiara","year":"2004","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.bbr.2017.12.026_bib0225","first-page":"393","article-title":"Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse","volume":"7","author":"Zhu","year":"2008","journal-title":"CNS Neurol. Disord.-Drug Targets (Former Curr. Drug Targets-CNS Neurol. Disord.)"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817317266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817317266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T09:46:37Z","timestamp":1660211197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432817317266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":45,"alternative-id":["S0166432817317266"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2017.12.026","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2017.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}